Cleared Traditional

K870442 - QUANTASCOPE

K870442 is an FDA 510(k) clearance for QUANTASCOPE, manufactured by Vital Science Corp.. The device is a Class 2 Cardiovascular device with product code DXR cleared through the Traditional 510(k) pathway after a 189-day FDA review.

K870442 · Vital Science Corp. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 1987
Decision
189d
Days
Class 2
Risk

K870442 is an FDA 510(k) clearance for the QUANTASCOPE. Classified as Ballistocardiograph (product code DXR), Class II - Special Controls.

Submitted by Vital Science Corp. (Englewood, US). The FDA issued a Cleared decision on August 11, 1987 after a review of 189 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2320 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Vital Science Corp. devices

FDA 510(k) Submission Details - K870442

510(k) Number K870442 FDA.gov
FDA Decision Cleared Substantially Equivalent - NSE Converted (SN)
Date Received February 03, 1987
Decision Date August 11, 1987
Days to Decision 189 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
64d slower than avg
Panel avg: 125d · This submission: 189d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DXR Device Classification - Class 2, Special Controls

Product Code DXR Ballistocardiograph
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2320
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.